|
(+)-Aeroplysinin-1 |
|
|
ALX-350-256-M001 |
|
1 mg |
70.00 USD |
|
 |
|
|
BPIQ-I |
|
|
ALX-270-313-M001 |
|
1 mg |
140.00 USD |
|
|
|
|
BPIQ-II |
|
|
ALX-270-338-M001 |
|
1 mg |
140.00 USD |
|
|
|
|
bpV(phen) |
|
|
ALX-270-204-M005 |
|
5 mg |
53.00 USD |
|
|
|
ALX-270-204-M025 |
|
25 mg |
195.00 USD |
|
|
|
|
Butein |
|
|
ALX-350-246-M010 |
|
10 mg |
190.00 USD |
|
|
|
|
CL-387,785 |
|
|
ALX-270-314-M001 |
|
1 mg |
130.00 USD |
|
|
|
|
Compound 56 |
|
|
ALX-270-316-C500 |
|
500 µg |
135.00 USD |
|
|
|
|
Curcumin (high purity) |
|
|
ALX-350-028-M010 |
|
10 mg |
15.00 USD |
|
|
|
ALX-350-028-M050 |
|
50 mg |
60.00 USD |
|
|
|
ALX-350-028-M250 |
|
250 mg |
240.00 USD |
|
|
|
|
Daphnetin |
|
|
ALX-270-281-M005 |
|
5 mg |
25.00 USD |
|
|
|
ALX-270-281-M025 |
|
25 mg |
95.00 USD |
|
|
|
|
EGF Receptor (human) (651-658) |
|
|
ALX-155-021-M001 |
|
1 mg |
50.00 USD |
|
|
|
ALX-155-021-M005 |
|
5 mg |
200.00 USD |
|
|
|
|
EGF Receptor (human) (651-658) (N-Myristoylated) |
|
|
ALX-155-022-M001 |
|
1 mg |
60.00 USD |
|
|
|
ALX-155-022-M005 |
|
5 mg |
240.00 USD |
|
|
|
|
EGF Receptor (human) (652-657) |
|
|
ALX-155-023-M001 |
|
1 mg |
45.00 USD |
|
|
|
ALX-155-023-M005 |
|
5 mg |
180.00 USD |
|
|
|
|
EGF Receptor, Soluble (active) (human) ELISA Kit |
|
|
ALX-850-266-KI01 |
|
1 Kit |
664.00 USD |
|
|
|
|
(-)-Epigallocatechin gallate |
|
|
ALX-270-263-M010 |
|
10 mg |
20.00 USD |
|
|
|
ALX-270-263-M050 |
|
50 mg |
60.00 USD |
|
|
|
|
Erbstatin analog |
|
|
ALX-270-098-M005 |
|
5 mg |
55.00 USD |
|
|
|
|
FGF-21 (human) (recombinant) (His) |
|
|
ALX-201-407-C010 |
|
10 µg |
170.00 USD |
|
|
|
ALX-201-407-C050 |
|
50 µg |
440.00 USD |
|
|
|
|
FGF-23 (human):Fc (human) (recombinant) |
|
|
ALX-201-418-C010 |
|
10 µg |
230.00 USD |
|
|
|
ALX-201-418-C050 |
|
50 µg |
560.00 USD |
|
|
|
|
FGF-21 (mouse) (recombinant) (His) |
|
|
ALX-201-409-C010 |
|
10 µg |
220.00 USD |
|
|
|
ALX-201-409-C050 |
|
50 µg |
570.00 USD |
|
|
|
|
FGF-23 (R179Q Mutant) (human) (recombinant) (His) |
|
|
ALX-201-435-C010 |
|
10 µg |
290.00 USD |
|
|
|
|
FGF-19 (human) (recombinant) (His) |
|
|
ALX-201-420-C010 |
|
10 µg |
260.00 USD |
|
|
|
ALX-201-420-C050 |
|
50 µg |
660.00 USD |
|
|
|
|
FGF-21 (human) (recombinant) |
|
|
ALX-201-400-C010 |
|
10 µg |
295.00 USD |
|
|
|
ALX-201-400-C050 |
|
50 µg |
660.00 USD |
|
|
|
|
FGF-21 (human):Fc (human) (recombinant) |
|
|
ALX-201-404-C010 |
|
10 µg |
260.00 USD |
|
|
|
ALX-201-404-C050 |
|
50 µg |
560.00 USD |
|
|
|
|
FGF-21 (mouse) (recombinant) |
|
|
ALX-201-401-C010 |
|
10 µg |
270.00 USD |
|
|
|
ALX-201-401-C050 |
|
50 µg |
780.00 USD |
|
|
|
|
FGF-21 (mouse):Fc (human) (recombinant) |
|
|
ALX-201-406-C010 |
|
10 µg |
260.00 USD |
|
|
|
ALX-201-406-C050 |
|
50 µg |
560.00 USD |
|
|
|
|
FGF-23 (human) (recombinant) (His) |
|
|
ALX-201-423-C010 |
|
10 µg |
240.00 USD |
|
|
|
ALX-201-423-C050 |
|
50 µg |
580.00 USD |
|
|
|
|
Fumagillin |
|
|
ALX-350-119-MC05 |
|
0.5 mg |
65.00 USD |
|
|
|
ALX-350-119-M001 |
|
1 mg |
105.00 USD |
|
|
|
|
Genistein (synthetic) |
|
|
ALX-350-006-M010 |
|
10 mg |
25.00 USD |
|
|
|
ALX-350-006-M025 |
|
25 mg |
50.00 USD |
|
|
|
ALX-350-006-M050 |
|
50 mg |
90.00 USD |
|
|
|
ALX-350-006-M100 |
|
100 mg |
150.00 USD |
|
|
|
ALX-350-006-G001 |
|
1 g |
480.00 USD |
|
|
|
|
Kahalalide F - Discontinued Due to Patent Restrictions |
|
|
ALX-350-292-C500 |
|
500 µg |
 |
|
|
Klotho (Extracellular Domain) (human):Fc (human) (recombinant) |
|
|
ALX-201-433-C010 |
|
10 µg |
320.00 USD |
|
|
|
|
βKlotho (Extracellular Domain) (human):Fc (human) (recombinant) |
|
|
ALX-201-434-C010 |
|
10 µg |
320.00 USD |
|
|
|
|
Lavendustin A |
|
|
ALX-350-007-M001 |
|
1 mg |
75.00 USD |
|
|
|
ALX-350-007-M005 |
|
5 mg |
295.00 USD |
|
|
|
|
Lavendustin A methyl ester |
|
|
ALX-350-091-M001 |
|
1 mg |
50.00 USD |
|
|
|
ALX-350-091-M005 |
|
5 mg |
190.00 USD |
|
|
|
|
Lavendustin C |
|
|
ALX-270-066-M001 |
|
1 mg |
35.00 USD |
|
|
|
|
Lavendustin C methyl ester |
|
|
ALX-350-084-M001 |
|
1 mg |
50.00 USD |
|
|
|
ALX-350-084-M005 |
|
5 mg |
200.00 USD |
|
|
|
|
MAb to Collectrin (mouse) (2G5) |
|
|
ALX-803-322-C050 |
|
50 µg |
180.00 USD |
|
|
|
|
MAb to C-Peptide (human) (91/1F9) |
|
|
ALX-803-049-C100 |
|
100 µg |
300.00 USD |
|
|
|
|
MAb to EGF Receptor (human) (13G8) |
|
|
ALX-804-064-C100 |
|
100 µg |
380.00 USD |
|
|
|
|
MAb to EGF Receptor (human) (MGR1) |
|
|
ALX-804-572-C100 |
|
100 µg |
320.00 USD |
|
|
|
|
MAb to EGF Receptor (non-phosphorylated) (20G3) |
|
|
ALX-804-161-C100 |
|
100 µg |
453.00 USD |
|
|
|
|
MAb to EGF Receptor (phosphorylated) (pSer1047) (1H9) |
|
|
ALX-804-390-C100 |
|
100 µg |
453.00 USD |
|
|
|
|
MAb to EGF Receptor (phosphorylated) (Tyr1173) (9H2) |
|
|
ALX-804-160-C100 |
|
100 µg |
453.00 USD |
|
|
|
|
MAb to c-erbB-2 (human) (MGR2) |
|
|
ALX-804-573-C100 |
|
100 µg |
320.00 USD |
|
|
|
|
MAb to FGF-21 (FG224-7) |
|
|
ALX-804-736-C100 |
|
100 µg |
310.00 USD |
|
|
|
|
MAb to Hrs and Hrs-2 (A-5) |
|
|
ALX-804-382-C050 |
|
50 µg |
290.00 USD |
|
|
|
|
MAb to TRK Receptor (human) (MGR12) |
|
|
ALX-804-575-C100 |
|
100 µg |
320.00 USD |
|
|
|
|
MAb to Viable Rat beta Cells and RIN Cells (K14D10) |
|
|
ALX-803-052-C100 |
|
100 µg |
547.00 USD |
|
|
|
|
PD 156,273 |
|
|
ALX-270-319-M001 |
|
1 mg |
150.00 USD |
|
|
|
|
PD 168,393 |
|
|
ALX-270-322-M001 |
|
1 mg |
156.00 USD |
|
|
|
|
PD 174,265 |
|
|
ALX-270-323-M001 |
|
1 mg |
130.00 USD |
|
|
|
|
PDGF Fragment (phosphorylated) (cyclic) |
|
|
ALX-165-019-MC01 |
|
0.1 mg |
50.00 USD |
|
|
|
ALX-165-019-M001 |
|
1 mg |
250.00 USD |
|
|
|
